Written question asked by Angela Watkinson (Conservative) on Thursday, 12 October 2006, in the House of Commons. It was due for an answer on Monday, 16 October 2006. It was answered by Andy Burnham (Labour) on Friday, 20 October 2006 on behalf of the Department of Health.
Pfizer Products
- Question
- (2) what assessment the Department has made of the impact on the NHS of the decision by Pfizer to sell its products through a single distribution channel from early 2007.
- Answer
-
This is a commercial matter for Pfizer. Pfizer have assured the Department that it will make every effort to ensure that these new arrangements will not result in any disruptions in the supply of its United Kingdom-sourced branded medicines to national health service patients. The Department will monitor these new arrangements with a view to taking corrective action if appropriate.
Secondary information
- Type
- Written question
- Reference
- 94520; 450 c1475-6W;450 c1481-2W
- Session
- 2005-06
- Subjects
- Drugs NHS Prescription drugs
- Link
- View this Written question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2013-11-25 15:05:20 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1173717
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1173717
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1173717